Introduction: A minority of patients satisfying diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have autoantibodies against components of nodal and paranodal structures in peripheral nerves. These patients are less likely to respond to intravenous immunoglobulin (IVIg) treatment and are more responsive to B cell depletion.
Leto et al. (Sun,) studied this question.